EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

JAK2, CALR, and MPL Mutation Profiles in Colombian patients with BCR-ABL Negative Myeloproliferative Neoplasms

Ana Isabel Giraldo-Rincón iD, Sara Naranjo Molina iD, Natalia Gomez-Lopera iD, Daniel Aguirre Acevedo iD, Andrea Ucroz Benavidez iD, Kenny Gálvez Cárdenas iD, Francisco Cuellar Ambrosí iD, Jose Domingo Torres iD, Sigifredo Ospina iD, Katherine Palacio iD, Lina Gaviria Jaramillo iD, Carlos Mario Muñeton iD und 1 weitere

Colombia Medica · 2023

DOI: 10.25100/cm.v54i3.5353 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Colombia Medica, 2023. Verfasst von Ana Isabel Giraldo-Rincón und 12 weiteren Autor:innen. Beteiligte Einrichtung: Universidad de Antioquia, Facultad de Medicina, Unidad de Genética Médica, Medellín, Colombia. Hauptthemen laut MEDLINE: Janus Kinase 2, Myeloproliferative Disorders, Receptors, Thrombopoietin, Calreticulin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BackgroundAmong the chronic myeloproliferative neoplasms (MPNs) not associated with BCR-ABL mutations are polycythemia vera, primary myelofibrosis, and essential thrombocythemia. These diseases are caused by gene mutations, such as the JAK2, MPL, and CALR genes, which regulate the JAK-STAT signaling pathway. ObjectiveThis study aimed to establish the frequencies of mutations in the JAK2, MPL, and CALR genes in Colombian patients with a negative clinical diagnosis of BCR-ABL chronic myeloproliferative neoplasms. MethodsThe JAK2 V617F and MPL W515K mutations and deletions or insertions in exon 9 of the CALR gene were analyzed in 52 Colombian patients with polycythemia vera, primary myelofibrosis, and essential thrombocythemia. ResultsThe JAK2V617F mutation was carried by 51.9% of the patients, the CALR mutation by 23%, and the MPL mutation by 3.8%; 23% were triple-negative for the mutations analyzed. Six mutation types in CALR were identified in these neoplasms, one of which has not been previously reported. Additionally, one patient presented a double mutation in the CALR and JAK2 genes. Regarding the hematological results for the mutations, significant differences were found in the hemoglobin level, hematocrit level, and platelet count among the three neoplasms. ConclusionThus, this study demonstrates the importance of the molecular characterization of the JAK2, CALR and MPL mutations in Colombian patients (the genetic context of which remains unclear in the abovementioned neoplasms) to achieve an accurate diagnosis, a good prognosis, adequate management, and patient survival.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Janus Kinase 2Myeloproliferative DisordersReceptors, ThrombopoietinCalreticulinHumansColombiaMutationPolycythemia VeraPrimary MyelofibrosisThrombocythemia, Essential

Stichwörter der Autor:innen

CARLColombiaJAK2MPLmyeloproliferative disorderpolycythemia veraprimary myelofibrosisthrombocythemia essential

Substanzen

JAK2 protein, humanJanus Kinase 2MPL protein, humanReceptors, ThrombopoietinCALR protein, humanCalreticulin

Autor:innen und Institutionen

  • Universidad de Antioquia, Facultad de Medicina, Unidad de Genética Médica, Medellín, Colombia.
  • Universidad de Antioquia, Grupo Académico de Epidemiología Clinica, Medellin, Colombia.
  • Hospital Pablo Tobón Uribe, Medellín, Colombia.
  • Hospital Alma Mater, Medellín, Colombia.
  • Hospital Universitario San Vicente Fundación, Medellín, Colombia.

ORCID-Profile: Ana Isabel Giraldo-Rincón, Sara Naranjo Molina, Natalia Gomez-Lopera, Daniel Aguirre Acevedo, Andrea Ucroz Benavidez, Kenny Gálvez Cárdenas, Francisco Cuellar Ambrosí, Jose Domingo Torres, Sigifredo Ospina, Katherine Palacio, Lina Gaviria Jaramillo, Carlos Mario Muñeton, Gonzalo Vasquez Palacio

Zitieren

APA

Giraldo-Rincón, A. I., Naranjo Molina, S., Gomez-Lopera, N., Aguirre Acevedo, D., Ucroz Benavidez, A., Gálvez Cárdenas, K., Cuellar Ambrosí, F., Torres, J. D., Ospina, S., Palacio, K., Gaviria Jaramillo, L., Muñeton, C. M., & Vasquez Palacio, G. (2023). JAK2, CALR, and MPL Mutation Profiles in Colombian patients with BCR-ABL Negative Myeloproliferative Neoplasms. Colombia Medica. https://doi.org/10.25100/cm.v54i3.5353

Vancouver

Giraldo-Rincón AI, Naranjo Molina S, Gomez-Lopera N, Aguirre Acevedo D, Ucroz Benavidez A, Gálvez Cárdenas K, et al. JAK2, CALR, and MPL Mutation Profiles in Colombian patients with BCR-ABL Negative Myeloproliferative Neoplasms. Colombia Medica. 2023. doi:10.25100/cm.v54i3.5353

BibTeX
@article{GiraldoRincn2023,
  author = {Giraldo-Rincón, Ana Isabel and Naranjo Molina, Sara and Gomez-Lopera, Natalia and Aguirre Acevedo, Daniel and Ucroz Benavidez, Andrea and Gálvez Cárdenas, Kenny and Cuellar Ambrosí, Francisco and Torres, Jose Domingo and Ospina, Sigifredo and Palacio, Katherine and Gaviria Jaramillo, Lina and Muñeton, Carlos Mario and Vasquez Palacio, Gonzalo},
  title = {JAK2, CALR, and MPL Mutation Profiles in Colombian patients with BCR-ABL Negative Myeloproliferative Neoplasms},
  journal = {Colombia Medica},
  year = {2023},
  doi = {10.25100/cm.v54i3.5353}
}
Kostenlos starten →